100 related articles for article (PubMed ID: 18032414)
1. Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli.
Kumano-Kuramochi M; Xie Q; Sakakibara Y; Niimi S; Sekizawa K; Komba S; Machida S
J Biochem; 2008 Feb; 143(2):229-36. PubMed ID: 18032414
[TBL] [Abstract][Full Text] [Related]
2. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE.
Nakano N; Fukuhara-Takaki K; Jono T; Nakajou K; Eto N; Horiuchi S; Takeya M; Nagai R
J Biochem; 2006 May; 139(5):821-9. PubMed ID: 16751589
[TBL] [Abstract][Full Text] [Related]
3. Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability.
Kumano-Kuramochi M; Ohnishi-Kameyama M; Xie Q; Niimi S; Kubota F; Komba S; Machida S
Biochem Biophys Res Commun; 2009 Aug; 386(1):130-4. PubMed ID: 19501570
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli.
Wilton R; Yousef MA; Saxena P; Szpunar M; Stevens FJ
Protein Expr Purif; 2006 May; 47(1):25-35. PubMed ID: 16510295
[TBL] [Abstract][Full Text] [Related]
5. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
Allmen EU; Koch M; Fritz G; Legler DF
Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction.
Matsumoto S; Yoshida T; Murata H; Harada S; Fujita N; Nakamura S; Yamamoto Y; Watanabe T; Yonekura H; Yamamoto H; Ohkubo T; Kobayashi Y
Biochemistry; 2008 Nov; 47(47):12299-311. PubMed ID: 19032093
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
Yan SF; Ramasamy R; Schmidt AM
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
[TBL] [Abstract][Full Text] [Related]
8. [Prokaryotic expression and activity identification of recombinant human soluble receptor for advanced glycation end products].
Zhao SC; Jiang Y; Liu JH; Li ZJ; Deng P; Zhang GL; Liu ZQ; Zhang X; Hou FF
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):769-73. PubMed ID: 16027063
[TBL] [Abstract][Full Text] [Related]
9. Effects of extracellular matrix glycosylation on proliferation and apoptosis of human dermal fibroblasts via the receptor for advanced glycosylated end products.
Niu Y; Xie T; Ge K; Lin Y; Lu S
Am J Dermatopathol; 2008 Aug; 30(4):344-51. PubMed ID: 18645306
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
Kuniyasu H; Chihara Y; Takahashi T
Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
13. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
Yan SF; D'Agati V; Schmidt AM; Ramasamy R
Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro.
Yoshida T; Park JS; Yokosuka K; Jimbo K; Yamada K; Sato K; Takeuchi M; Yamagishi S; Nagata K
Spine (Phila Pa 1976); 2009 Jul; 34(15):1544-8. PubMed ID: 19564763
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
Mohan SK; Gupta AA; Yu C
Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
[TBL] [Abstract][Full Text] [Related]
17. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
Dattilo BM; Fritz G; Leclerc E; Kooi CW; Heizmann CW; Chazin WJ
Biochemistry; 2007 Jun; 46(23):6957-70. PubMed ID: 17508727
[TBL] [Abstract][Full Text] [Related]
18. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.
Hirata K; Takada M; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2003; 50(53):1205-7. PubMed ID: 14571699
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE).
Monteiro FA; Cardoso I; Sousa MM; Saraiva MJ
FEBS Lett; 2006 Jun; 580(14):3451-6. PubMed ID: 16716307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
